home
docs

Syrian Arab Republic Access to anti-retroviral drugs, female (%) 2026: Interactive Chart & Historical Data

Access to anti-retroviral drugs, female (%) in Syrian Arab Republic stood at 41% in 2024, according to World Bank. The latest value is up 1 percentage points from 40% in 2023. Ten years earlier, in 2014, the value was 26% (up 15 percentage points since). The highest value since 2000 was 44% in 2020, the lowest 0% in 2000. Syrian Arab Republic ranked 109th highest of the 123 countries in this dataset in 2024; Azerbaijan ranked first.

Data source: World Bank · Unit: % · Category: Demographics · Explore more indicators on EconDash

Data updated:Last checked:Frequency:AnnualCoverage:2000–2024

Key facts

What is the latest Access to anti-retroviral drugs, female (%) in Syrian Arab Republic?

Access to anti-retroviral drugs, female (%) in Syrian Arab Republic stood at 41% in 2024, according to World Bank.

Is Access to anti-retroviral drugs, female (%) in Syrian Arab Republic rising or falling?

The latest value is up 1 percentage points from 40% in 2023. Ten years earlier, in 2014, the value was 26% (up 15 percentage points since).

How does Syrian Arab Republic rank for Access to anti-retroviral drugs, female (%)?

Syrian Arab Republic ranked 109th highest of the 123 countries in this dataset in 2024; Azerbaijan ranked first.

What is the highest Access to anti-retroviral drugs, female (%) on record in Syrian Arab Republic?

The highest value since 2000 was 44% in 2020, the lowest 0% in 2000.

Metadata for Access to anti-retroviral drugs, female (%) in Syrian Arab Republic
IndicatorAccess to anti-retroviral drugs, female (%)
CountrySyrian Arab Republic
CategoryDemographics
Unit%
SourceWorld Bank
Interactive chartView on EconDash
API accessEconDash API documentation

Latest value: 41% (2024)

Loading chart...

Source:World Bank — series SH.HIV.ARTC.FE.ZS
License:CC BY 4.0
Cite this chart
APA

World Bank. (2026). Access to anti-retroviral drugs, female (%) — Syrian Arab Republic [Data set]. Retrieved November 13, 2026, from EconDash: https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/SYR. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS

MLA

World Bank. "Access to anti-retroviral drugs, female (%) — Syrian Arab Republic." EconDash, 2026, https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/SYR. Accessed 13 Nov. 2026. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS.

Chicago

World Bank. 2026. "Access to anti-retroviral drugs, female (%) — Syrian Arab Republic." EconDash. Accessed November 13, 2026. https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/SYR. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS.

BibTeX
@misc{econdash_wdi_sh_hiv_artc_fe_zs_syr,
  author = {{World Bank}},
  title = {{Access to anti-retroviral drugs, female (\%) --- Syrian Arab Republic}},
  howpublished = {EconDash},
  year = {2026},
  url = {https://econdash.org/chart/wdi-sh-hiv-artc-fe-zs/SYR},
  note = {Accessed: 2026-11-13. Original source: https://data.worldbank.org/indicator/SH.HIV.ARTC.FE.ZS}
}